The health behemoth beat Wall Street forecasts for both earnings and revenue in fourth quarter as care consumption and prescriptions returned to more typical levels despite fears of renewed deferrals as COVID-19 cases surge.
The health behemoth beat Wall Street forecasts for both earnings and revenue in fourth quarter as care consumption and prescriptions returned to more typical levels despite fears of renewed deferrals as COVID-19 cases surge.
Copyright © 2024 | WordPress Theme by MH Themes
